Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Genesis Healthcare

Request full access

A privately-owned Japanese genetic testing and research company

Tokyo, JapanFounded 2004Biotech & Life Sciences

About Genesis Healthcare

Established in 2004, Genesis Healthcare Co. stands as a significant player in Japan's genetic testing and research sector. The company was founded by Dr. Iri Sato Baran, whose background in biomedical sciences and doctoral studies at Tokai University School of Medicine provided a strong foundation for the company's scientific pursuits. Her journey began with a desire to make genetic information more accessible and to promote preventative healthcare in Japan, a vision that has driven the company's strategy.

Genesis Healthcare operates on a dual-front business model, catering to both consumers and the scientific community. Its direct-to-consumer brand, GeneLife, has established itself as a market leader in Japan, offering a range of at-home genetic testing kits. These kits, such as GeneLife Genesis 2.0 and GeneLife DIET, provide individuals with insights into their health risks, physical constitution, and ancestry, with the goal of encouraging proactive health management. The kits analyze DNA from saliva samples to deliver personalized reports.

On the B2B side, the company leverages its extensive genetic database, the largest in Asia, to provide research services and clinical testing. This division collaborates with medical institutions, research organizations, and corporate partners, utilizing advanced PCR, Microarray, and Next-Generation Sequencing (NGS) technologies. Revenue is generated through the sale of GeneLife testing kits to consumers and through fees for its research and testing services to institutional clients. A notable milestone was a strategic capital and business alliance with Rakuten in 2017, which integrated genetic testing services into the e-commerce giant's ecosystem, significantly expanding market reach.

The company also emphasizes its role in shaping the regulatory landscape for genetic testing in Japan, working with government bodies to establish guidelines for data security and accuracy. This focus on data integrity is crucial, as the company manages a substantial biobank and database, which also supports population-level genomic research initiatives.

Source: Dealroom company data

At a glance

Status
Operational
Employees
24
Open positions
None listed
Dealroom signal
47.0/100
Industry
Health
Sub-industry
BioTechnology
Sector
Testing, Biotechnology, Genetics and genomics, Biotech and Pharma, Hard Tech, medical testing, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

5 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
LATE VCOther financing Jul 2019 $13M $54M Undisclosed —
EARLY VCOther financing Feb 2018 $13M $52M Omron Healthcare —
Showing the latest 2 of 5 recorded eventsBook a demo for the full funding history →

Growth signals

Genesis Healthcare website traffic

Latest recorded traffic for Genesis Healthcare is 2.6K monthly website visits, up 23.8% over the last three months. Genesis Healthcare's team grew 9.1% over the past year.

Latest monthly visits2.6K 3-month web change+23.8% 1-year team growth+9.1%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Genesis Healthcare in the Tokyo ecosystem

Live from Dealroom

The Genesis Healthcare office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

6 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed2 investors entered at this stage

  • Mitsui Global Investment
  • Tokyo Founders Fund

Series A1 investor entered at this stage

  • Omron Healthcare

Other known investors3 additional known investors

  • Ci:z Investment
  • Rakuten
  • Rakuten Capital
Team profiled 6 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
3 countries with
team presence
🇯🇵 Japan60%
🇹🇼 Taiwan30%
🇺🇸 United States10%
3 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Genesis Healthcare on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Genesis Healthcare’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.